We are live on ! Find out more
UTMD icon

Utah Medical Products

68 hedge funds and large institutions have $158M invested in Utah Medical Products in 2016 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 16

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

7% more capital invested

Capital invested by funds: $147M → $158M (+$10.9M)

6% more funds holding

Funds holding: 6468 (+4)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
68
Holders Change
+4
Holders Change %
+6.25%
% of All Funds
1.81%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
12
Increased
26
Reduced
16
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Acadian Asset Management
51
Acadian Asset Management
Massachusetts
$165K
BA
52
BlackRock Advisors
Delaware
$138K +$17.2K +292 +15%
AIG
53
American International Group
New York
$137K
SO
54
STRS Ohio
Ohio
$118K +$88.5K +1,500 +375%
SEI Investments
55
SEI Investments
Pennsylvania
$99K +$15.2K +258 +20%
AIM
56
Acrospire Investment Management
Illinois
$99K +$92.9K +1,576 New
ASN
57
Advisory Services Network
Georgia
$53K
Fuller & Thaler Asset Management
58
Fuller & Thaler Asset Management
California
$50K +$47.2K +800 New
Creative Planning
59
Creative Planning
Kansas
$27K
PNC Financial Services Group
60
PNC Financial Services Group
Pennsylvania
$21K +$59 +1 +0.3%
Royal Bank of Canada
61
Royal Bank of Canada
Ontario, Canada
$16K -$767 -13 -5%
PCM
62
Prelude Capital Management
New York
$13K -$17.7K -300 -60%
BlackRock
63
BlackRock
New York
$8K +$7.61K +129 New
Bank of America
64
Bank of America
North Carolina
$6K -$5.31K -90 -47%
Barclays
65
Barclays
United Kingdom
$6K +$5.9K +100 New
BNP Paribas Financial Markets
66
BNP Paribas Financial Markets
France
$2.56K -$44.6K -757 -95%
Geode Capital Management
67
Geode Capital Management
Massachusetts
$2.18K +$284K +4,815 +16%
DA
68
Denali Advisors
California
$2K
OCG
69
Opus Capital Group
Ohio
-$3.21M -54,836 Closed
CIC
70
Crawford Investment Counsel
Georgia
-$689K -11,766 Closed
B
71
Bailard
California
-$488K -8,330 Closed
CIS
72
Connors Investor Services
Pennsylvania
-$248K -4,243 Closed
Two Sigma Investments
73
Two Sigma Investments
New York
-$205K -3,498 Closed
PA
74
Perceptive Advisors
New York
-$107K -1,828 Closed
WBC
75
Westpac Banking Corp
Australia
-$80.3K -1,371 Closed

UTMD Hedge Fund Activity: Q1 2016 in Review

68 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q1 2016, worth a combined $158M — up 7.4% from $147M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new UTMD positions and 8 closed out — a net gain of 4 holders — while 26 added to existing stakes and 16 trimmed.

The largest buyer was WCM Investment Management, opening a new position worth an estimated $3.44M. The largest seller was Opus Capital Group, exiting entirely with an estimated $3.21M sold.

  • 68 institutional investors held Utah Medical Products (UTMD) as of Q1 2016, up from 64 in Q4 2015.
  • Funds reported $158M of Utah Medical Products stock for Q1 2016, up 7.4% quarter-over-quarter.
  • 12 funds opened new Utah Medical Products positions in Q1 2016 and 8 closed out, a net change of +4 holders.
  • The largest Utah Medical Products buyer in Q1 2016 was WCM Investment Management, an estimated $3.44M added.
  • The largest Utah Medical Products seller in Q1 2016 was Opus Capital Group, an estimated $3.21M sold.

Based on aggregated 13F filings for Q1 2016.